SecBot SecBot
SECBOTREPLAY Home › Report › SCYX

SCYX · SCYNEXIS filed an 8-K reporting shareholder approval to increase…

SCYNEXIS INC · 8-K filed Jun 26, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Jun 26, 2026 at 16:01 ET

SCYNEXIS filed an 8-K reporting shareholder approval to increase authorized common stock from 18.75M to 60M shares (post reverse-split), enabling the exercise of outstanding warrants held by selling stockholders. The filing also confirms the effectiveness of a previously filed S-3 registration statement covering up to 10.875M post-split shares for resale. This is a procedural step in the capital restructuring announced in March 2026, with no new financial disclosures or immediate fundraising.

  • Authorized common stock increased from 18,750,000 to 60,000,000 shares (post-1-for-8 reverse split effective May 29, 2026).
  • Shareholders approved the amendment at the June 25, 2026 Annual Meeting.
  • Registration statement on Form S-3 (effective May 8, 2026) registers up to 10,875,000 post-split shares for resale by selling stockholders.
  • Warrants (pre-funded and common) became exercisable upon the effectiveness of the authorized share increase on June 26, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access